Enavate Sciences GP, LLC
- SEC CIK
- 0001953107
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 7
- 0 vs. Q4 2025
- Portfolio value
- $351.5M
- −$155.3M (−30.6%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SIONSionna Therapeutics, Inc. | COM | 2,478,030 | $99.3M | 28.3% | 00.0% | Unchanged | History |
| IMNMImmunome Inc. | COM | 3,613,799 | $79.0M | 22.5% | −1,154,784−24.2% | Reduced | History |
| ZBIOZenas BioPharma, Inc. | COM | 3,919,159 | $76.6M | 21.8% | 00.0% | Unchanged | History |
| CMPXCompass Therapeutics, Inc. | COM | 7,788,150 | $41.2M | 11.7% | 00.0% | Unchanged | History |
| BBOTBridgeBio Oncology Therapeutics, Inc. | COM NEW | 2,626,946 | $23.5M | 6.7% | 00.0% | Unchanged | History |
| UPBUpstream Bio, Inc. | COM | 2,459,703 | $22.1M | 6.3% | 00.0% | Unchanged | History |
| CAMPCamp4 Therapeutics Corp | COM | 2,190,920 | $9.66M | 2.7% | −844,905−27.8% | Reduced | History |